NAOV NanoVibronix, Inc.

Nasdaq nanovibronix.com


$ 5.70 $ 0.00 (0 %)    

Thursday, 23-Oct-2025 07:51:06 EDT
QQQ $ 608.42 $ 3.51 (0.58 %)
DIA $ 466.24 $ 0.69 (0.15 %)
SPY $ 670.10 $ 2.00 (0.3 %)
TLT $ 91.68 $ 0.07 (0.08 %)
GLD $ 381.45 $ -0.02 (-0.01 %)
$ 5.74
$ 5.70
$ 5.70 x 120
$ 5.86 x 100
-- - --
$ 4.71 - $ 162.50
85,355
na
4.57M
$ 2.59
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-19-2025 06-30-2025 10-Q
2 05-20-2025 03-31-2025 10-Q
3 03-31-2025 12-31-2024 10-K
4 11-14-2024 09-30-2024 10-Q
5 08-14-2024 06-30-2024 10-Q
6 05-15-2024 03-31-2024 10-Q
7 04-08-2024 12-31-2023 10-K
8 11-13-2023 09-30-2023 10-Q
9 08-11-2023 06-30-2023 10-Q
10 05-15-2023 03-31-2023 10-Q
11 04-17-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-15-2022 06-30-2022 10-Q
14 05-16-2022 03-31-2022 10-Q
15 04-14-2022 12-31-2021 10-K
16 11-15-2021 09-30-2021 10-Q
17 08-16-2021 06-30-2021 10-Q
18 05-24-2021 03-31-2021 10-Q
19 04-15-2021 12-31-2020 10-K
20 11-16-2020 09-30-2020 10-Q
21 08-19-2020 06-30-2020 10-Q
22 07-06-2020 03-31-2020 10-Q
23 05-20-2020 12-31-2019 10-K
24 11-19-2019 09-30-2019 10-Q
25 08-14-2019 06-30-2019 10-Q
26 05-20-2019 03-31-2019 10-Q
27 04-15-2019 12-31-2018 10-K
28 11-14-2018 09-30-2018 10-Q
29 08-14-2018 06-30-2018 10-Q
30 05-15-2018 03-31-2018 10-Q
31 03-29-2018 12-31-2017 10-K
32 11-14-2017 09-30-2017 10-Q
33 08-14-2017 06-30-2017 10-Q
34 05-15-2017 03-31-2017 10-Q
35 03-31-2017 12-31-2016 10-K
36 11-14-2016 09-30-2016 10-Q
37 08-15-2016 06-30-2016 10-Q
38 05-16-2016 03-31-2016 10-Q
39 03-30-2016 12-31-2015 10-K
40 11-16-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 nanovibronix-announces-2m-registered-direct-offering-of-291204-shares-at-701share

NanoVibronix, Inc. (NASDAQ:NAOV) ("NanoVibronix" or the "Company"), a medical technology company specializing i...

 why-nanovibronix-naov-stock-is-skyrocketing-today

NanoVibronix shares are trading sharply higher on Monday. The company announced a new U.S. patent granted to its wholly-owned s...

 nanovibronix-announces-that-its-wholly-owned-subsidiary-envue-medical-holdings-has-been-granted-a-us-patent-for-the-companys-proprietary-method-for-overlaying-electromagnetic-navigation-data-onto-real-time-medical-imaging

Patent strengthens company's leadership in feeding tube placement and opens path to broader vascular navigation marketNanoV...

 nanovibronix-announces-official-launch-of-next-gen-robotic-development-initiative-within-envue-medical-division

ENvue Targeting $10 Billion+ Market Opportunity with Scalable AI-Enhanced Clinical RoboticsNanoVibronix, Inc. (NASDAQ:NAOV) (&#...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION